Lentigo Maligna/Lentigo Maligna Melanoma: Current State of Diagnosis and Treatment

BACKGROUND Lentigo maligna (LM) is a subtype of melanoma in situ that typically develops on sun-damaged skin. Presentation may be quite subtle and delayed diagnosis is common. Clinical margins are often ill defined. Histologic evaluation can be difficult due to the widespread atypical melanocytes that are present in the background of long-standing sun damage. Recurrence following standard therapies is common. OBJECTIVE To review the clinical features, histopathology, and treatment options for LM. Emphasis is placed on recent advances in the treatment of LM. METHODS AND MATERIALS Literature review. RESULTS The estimated lifetime risk of LM progressing to LM melanoma is 5%. Standard excision of LM with 5 mm margins is insufficient in 50% of cases. The recurrence rate with standard excision ranges from 8 to 20%. Mohs surgery and staged excision may offer better margin control and lower recurrence rates (4–5%). Estimates of recurrence rates following nonsurgical therapies such as cryosurgery, radiotherapy, electrodessication and curettage, laser surgery, and topical medications range from 20 to 100% at 5 years. CONCLUSIONS Adequate treatment of LM requires a comprehensive knowledge of the diagnostic features, histopathology, and treatment options. Surgical modalities with meticulous evaluation of tissue margins appears to offer the lowest rates of disease recurrence.

[1]  M. Mihm,et al.  The histopathology of cutaneous malignant melanoma. , 1993, Seminars in diagnostic pathology.

[2]  J. Carucci.  Treatment of lentigo maligna. , 2001, Cutis.

[3]  W. Weyers,et al.  Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis. , 1996, The American Journal of dermatopathology.

[4]  Cohen Lm,et al.  Recurrent lentigo maligna invading a skin graft successfully treated with Mohs' micrographic surgery. , 1996 .

[5]  R. Barnhill.  Pathology and prognostic factors , 1993, Current opinion in oncology.

[6]  E. Farmer,et al.  Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. , 1996, Human pathology.

[7]  Fei Liu,et al.  Lentigo maligna of the head and neck. Results of treatment by radiotherapy. , 1994, Archives of dermatology.

[8]  R. Grekin,et al.  510-nm pigmented lesion dye laser. Its characteristics and clinical uses. , 1993, The Journal of dermatologic surgery and oncology.

[9]  I. Zalaudek,et al.  Clinical and Laboratory Investigations Local recurrence in melanoma in situ: influence of sex, age, site of involvement and therapeutic modalities , 2003 .

[10]  G. Plewig,et al.  Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients. , 2000, Journal of the American Academy of Dermatology.

[11]  J. Kelly.  Following lentigo maligna may not prevent the development of life-threatening melanoma. , 1992, Archives of dermatology.

[12]  A. Slee,et al.  Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up. , 2004, Archives of dermatology.

[13]  J. Morelli,et al.  Pulsed dye laser treatment of benign cutaneous pigmented lesions , 1993, Lasers in surgery and medicine.

[14]  S. Iyer,et al.  Treatment of lentigo maligna with combination laser therapy: recurrence at 8 months after initial resolution , 2003, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[15]  S. Gruber,et al.  Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis. , 1989, Journal of the American Academy of Dermatology.

[16]  H. Rabinovitz,et al.  Lentigo maligna. The use of rush permanent sections in therapy. , 1990 .

[17]  A. Harwood.  Conventional fractionated radiotherapy for 51 patients with lentigo maligna and lentigo maligna melanoma. , 1983, International journal of radiation oncology, biology, physics.

[18]  E. R. Farmer,et al.  NIH Consensus conference. Diagnosis and treatment of early melanoma. , 1992, JAMA.

[19]  J. Callen,et al.  Successful treatment of lentigo maligna and lentigo maligna melanoma with mohs' micrographic surgery aided by rush permanent sections , 1994, Cancer.

[20]  E. B. Helwig,et al.  Melanotic freckle of hutchinson , 1968, Cancer.

[21]  R. Dummer,et al.  A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X‐rays , 2002, The British journal of dermatology.

[22]  V D Tewari,et al.  Lasers in Dermatology. , 1988, Indian journal of dermatology, venereology and leprology.

[23]  J. Berth-Jones,et al.  Imiquimod: a novel treatment for lentigo maligna , 2000, The British journal of dermatology.

[24]  E. Epstein.  Extensive lentigo maligna clearing with topical imiquimod. , 2003, Archives of dermatology.

[25]  F. Nahai,et al.  The meaning of surgical margins. , 1984, Plastic and reconstructive surgery.

[26]  M. Fallowfield,et al.  Epidermal melanocytes adjacent to melanoma and the field change effect , 1990, Histopathology.

[27]  D J Goldberg,et al.  Lasers in dermatology. , 1996, Journal of the American Academy of Dermatology.

[28]  S. Leachman,et al.  Histopathologic recognition of involved margins of lentigo maligna excised by staged excision: an interobserver comparison study. , 2003, Archives of dermatology.

[29]  R. Reed.  The Pathology of Human Cutaneous Melanoma , 1983 .

[30]  R. Anderson,et al.  TREATMENT OF BENIGN PIGMENTED EPIDERMAL LESIONS BY Q‐SWITCHED RUBY LASER , 1993, International journal of dermatology.

[31]  J. Dover,et al.  Visible action spectrum for melanin‐specific selective photothermolysis , 1989, Lasers in surgery and medicine.

[32]  L Lowe,et al.  Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: the "square" procedure. , 1997, Journal of the American Academy of Dermatology.

[33]  M. Weinstock,et al.  The risk of progression of lentigo maligna to lentigo maligna melanoma , 1987, The British journal of dermatology.

[34]  L. Cohen,et al.  Lentigo maligna and lentigo maligna melanoma. , 1995, Journal of the American Academy of Dermatology.

[35]  D. Ren,et al.  Cutaneous head and neck melanoma treated with Mohs micrographic surgery. , 2005, Journal of the American Academy of Dermatology.

[36]  W. Clark,et al.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.

[37]  K. Arndt.  Argon laser treatment of lentigo maligna. , 1984, Journal of the American Academy of Dermatology.

[38]  June K. Robinson,et al.  Margin control for lentigo maligna. , 1994, Journal of the American Academy of Dermatology.

[39]  K. Arndt.  New pigmented macule appearing 4 years after argon laser treatment of lentigo maligna. , 1986, Journal of the American Academy of Dermatology.

[40]  R. Fitzpatrick,et al.  Laser treatment of benign pigmented epidermal lesions using a 300 nsecond pulse and 510 nm wavelength. , 1993, The Journal of dermatologic surgery and oncology.

[41]  P. Mortimer,et al.  Aggressive amelanotic lentigo maligna , 1994, The British journal of dermatology.

[42]  J. Dover,et al.  Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm. , 1989, The Journal of investigative dermatology.

[43]  G. Fisher,et al.  Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease. , 2003, Archives of dermatology.

[44]  S. Ibbotson,et al.  A pilot study of treatment of lentigo maligna with 5% imiquimod cream , 2004, The British journal of dermatology.

[45]  W. Sterry,et al.  Amelanotic lentigo maligna melanoma. , 1995, Journal of the American Academy of Dermatology.

[46]  L. Cohen,et al.  Recurrent lentigo maligna invading a skin graft successfully treated with Mohs' micrographic surgery. , 1996, Cutis.

[47]  D. D. de Berker.  Lentigo maligna and Mohs. , 1991, Archives of dermatology.

[48]  Cramer Sf,et al.  Sequential histologic study of evolving lentigo maligna melanoma. , 1982 .

[49]  E. G. Kuflik.  Cryo Corner: Cryosurgery for Lentigo Maligna: A Report of Four Cases* , 1980 .

[50]  D. DiCaudo,et al.  Mohs micrographic excision of melanoma using immunostains. , 2000, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[51]  A. Sober,et al.  Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases. , 1998, Journal of the American Academy of Dermatology.

[52]  D. Metze,et al.  Topical Treatment of Lentigo maligna Melanoma with Imiquimod 5% Cream , 2003, Dermatology.

[53]  B. Hanusa,et al.  Surgical margins for excision of primary cutaneous melanoma. , 1997, Journal of the American Academy of Dermatology.

[54]  Edgar B. Smith,et al.  Spreading pigmented actinic keratosis. , 1983, Journal of the American Academy of Dermatology.

[55]  J. Brennick,et al.  Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream. , 2003, Archives of dermatology.

[56]  D. Goldberg,et al.  Benign pigmented lesions of the skin. Treatment with the Q-switched ruby laser. , 1993, The Journal of dermatologic surgery and oncology.

[57]  N. S. Penneys.  Microinvasive lentigo maligna melanoma. , 1987, Journal of the American Academy of Dermatology.

[58]  K J Dallimore,et al.  Lentigo maligna and lentigo maligna melanoma. , 1997, Journal of the American Academy of Dermatology.

[59]  A. Kauvar,et al.  Treatment of small and medium congenital nevi with the Q-switched ruby laser. , 1996, Archives of dermatology.

[60]  G. Bowen,et al.  Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. , 2002, Journal of the American Academy of Dermatology.

[61]  P. Hutchinson,et al.  A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision. , 2002, British journal of plastic surgery.

[62]  W. Clark,et al.  The classification of malignant melanoma and its histologic reporting , 1973, Cancer.

[63]  J. Zitelli.  Mohs surgery for lentigo maligna. , 1991, Archives of dermatology.

[64]  R. Malhotra,et al.  Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision. , 2004, Archives of dermatology.

[65]  T. Ohshiro,et al.  The ruby and argon lasers in the treatment of naevi. , 1983, Annals of the Academy of Medicine, Singapore.

[66]  L. Cohen,et al.  Mohs Micrographic Surgery for Lentigo Maligna and Lentigo Maligna Melanoma. A Follow‐up Study , 1998, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[67]  A. Rhodes.  Melanocytic precursors of cutaneous melanoma. Estimated risks and guidelines for management. , 1986, The Medical clinics of North America.

[68]  B. Hagberg,et al.  CLINICAL CHARACTERISTICS , 1972 .

[69]  Daniel Pinkel,et al.  Classifying melanocytic tumors based on DNA copy number changes. , 2003, The American journal of pathology.

[70]  T. Alster.  Complete Elimination of Large Café‐au‐LaitBirthmarks by the 510‐nm Pulsed Dye Laser , 1995, Plastic and reconstructive surgery.

[71]  J. Nelson,et al.  Treatment of Superficial Cutaneous Pigmented Lesions by Melanin-specific Selective Photothermolysis Using the Q-switched Ruby Laser , 1992, Annals of plastic surgery.

[72]  A. Gage,et al.  Cryosurgery for lentigo maligna. , 1994, Journal of the American Academy of Dermatology.

[73]  R. Kuwahara,et al.  Treatment of lentigo maligna with topical imiquimod , 2003, The British journal of dermatology.

[74]  R. Anderson,et al.  Treatment of cafe au lait macules with lasers. A clinicopathologic correlation. , 1995, Archives of dermatology.

[75]  W. White,et al.  Management of lentigo maligna and lentigo maligna melanoma with paraffin-embedded tangential sections: utility of immunoperoxidase staining and supplemental vertical sections. , 1993, Journal of the American Academy of Dermatology.

[76]  R. Knobler,et al.  Reactive lentiginous hyperpigmentation after cryosurgery for lentigo maligna. , 1992, Journal of the American Academy of Dermatology.

[77]  C. Maillo,et al.  Recurrent lentigo maligna as amelanotic lentigo maligna melanoma , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[78]  W. Clark,et al.  The biologic forms of malignant melanoma. , 1986, Human pathology.

[79]  N. Swanson,et al.  Mohs' micrographic surgery using frozen sections alone may be unsuitable for detecting single atypical melanocytes at the margins of melanoma in situ , 2002, The British journal of dermatology.

[80]  M. Schön,et al.  Reliability of diagnosis of melanoma in situ , 2002, The Lancet.

[81]  Gary S. Rogers,et al.  Diagnosis and Treatment of Early Melanoma: NIH Consensus Development Panel on Early Melanoma , 1992 .

[82]  L. Lowe,et al.  Treatment of head and neck melanoma, lentigo maligna subtype: a practical surgical technique. , 2001, Archives of facial plastic surgery.